available. A practical solution for this problem has been the development of the paper electrophoretic procedure for such separation of serum lipoproteins by Swahn7 and Jeneks et al. 8 Heretofore, these methods have not been found to be sufficiently reliable. 9"10 A new procedure for separating 5 lipidcontaining fractions of serum by paper eleetrophoresis and a method of quantitation have been reported from our laboratory." It is the purpose of this report to present the results of an initial study correlating lipoprotein distributions in "normal" individuals and in atherosclerotic patients.
Material and Method
The present series consists of 40 consecutive, unselected patients classified as abnormal on the basis of unequivocal evidence of one or more myoeardial infaretions or arteriosclerotic cerebrovasFrom the Department of Medical Research, Saint Joseph Hospital, Burbank, Calif. Supported in part by a grant from Searle and Company. 526 eular accidents. In addition, many of these patients presented ancillarv clinical symnptoms of cardiovascular disease such as angina, hypertension, nephroselerosis, retinopathy, arteriosclerotic gangrene, and positive familial histories of coronary disease. Three patients in this group also exhibited xanthomata with familial and refractory hypercholesteremia. In this group there were 32 males, ranging in age from 38 to 74 years, with a mean age of 55 years, and 8 females, ranging in age from 31 to 70 years, with a mean age of 54 years.
Another group of 40 individuals selected in the samie manner, represent the controls (normal). These were so classified by the exclusion of atherosclerotic cardiovascular disease on the basis of negative findings on routine history and physical examination and by electrocardiography. While this group of "normals" consisted chiefly of healthy individuals, some patients with nonrelated disease were included and admittedly some degree of asymptomatic atherosclerosis may be presumed to be present. This group is represented by 25 males ranging in age from 10 to 80 years, with a mean age of 48 years, and 15 females ranging from 11 to 70 years, with a mean age of 34 years.
Since this experiment was set up on a blind basis, initially 2 children, one of each sex, were included. If these are omitted, the age distribution for males is 33 to 80, with a mean age of 49 years, and for feimales 23 to 70, with a mean age of 47 years.
The usual clinical evaluation also included laboratory examinations such as complete blood counts, urinalysis, serum protein-bound iodine, liver-funetion tests, blood glucose, serum urea nitrogen and uric acid, blood serologic tests, and Papanicolaou tests of vaginal exfoliated cells. The results of these tests were found to be noncontributory and are not further considered.
Fasting blood specimens were drawn in the early morning and all analytical procedures were started within 24 hours. The lipid spectrum for each individual was determined as follows: the concentra- values of alpha-2, alpha-1, and lipalbumin fractions. Beta/lipalbumin ratios were derived similarly from the values of these individual fractions.
Statistical constants were calculated according to standard methods.'6 Significance of differences between groups was determined by the Fisher t test, for which a value of 3.0 or more was considered by us to be acceptable.
Each type of datum also was examined for its significance in predicting the atherosclerotic status of the individual. For this purpose, the percentage of normal individuals was determined at each level of the variable being examined. Two levels of figure 5 . It is of illterest to examiuie these fractions individually anid in combinationi for the degree to whlich they correlate with imanifest coroniary arterv disease and, conversely, the extent to which they can be used as a diagnlostic index.
Gamma Lipoprotein Plus Neutral Fat Fraction
The least significant of all the vTariables measured in this portion of the study appears to be the gamma lipoprotein anid nieutral fat fraetion. Figure 6 The distribution of the relative concentrations of alpha-2 lipoproteins is shown in figure  8 . It will be noted that each group, as well as the total population, displays a well-normalized frequency distribution. Although a considerable degree of overlapping is noted, comparison of the mean values for the 2 groups is found to be significantly different (t = 4.14). In addition, the possibility of differentiatinig "normal" from abnlormal oni an individual basis is considerably increased since 55 per cent of the total population can be classified with 80 per cent reliability, whereas only 11 per cent of the sample can be classified with absolute assurance.
Beta Lipoproteins
Our findings with respect to the relative concentrations of beta lipoproteins are shownl in figure 9 . figure 10 , from which it can be seen that overlapping values for the "normal" and abnormal subjects occur in a narrow portion of the enitire range and include a relatively small fraction of the entire population. It appears possible to identify the atherosclerotic status of an individual with absolute certainty if the lipalbumin concenitration is below 10.4 or above 21.5 per cent. The tail-ends of the distribution beginning with these values include 26 individuals, or 32 per cent of the sample. If one accepts a 4 to 1 probability for correct diagnosis, then 56 per cent of the population can be satisfactorily classified when the concentration is below 12.7 and above 17.7 per cent. The calculated Fisher's t of 5.78 also indicates that the difference in the means for the 2 groups is highly significant.
Beta/Alpha Ratio
The distribution of the beta /alpha ratios for "'normal'" and patients with manifest eoronary artery disease is showin in figure 11 , To conform with the beta/alpha ratios published by others17' 1' the lipalbumin, alpha-I, The qualitative character of the lipoproteini patterni prepared by our method of electrophoresis reveals that the alpha lipoproteins represent a minor portion of the lipoprotein pattern and, therefore, can be expected to make a small contribution to the foregoing beta/alpha ratio. The lipalbumin fraction, oni the other hand, represents a larger physical share of the pattern and plays a greater determinant role in the calculation of this ratio. AVe have examined, therefore, our data with respect to the usefulness of the beta/lipalbumin ratio in our sample population ( figure  12 ). This index displays a high degree of reliability (t = 4.65) for the separation of niormal"' and abnormal groups. In additioni it will be noted that the atherosclerotic status of one third of our population can be correctly classified without chance of error, when this variable is below 2.56 or greater than 6.82. On the other hand, if an 80 per cenit level of confidence is acceptable, more than half of the population can be diagnosed whein values are less than 2.97 or more than 5.12 (table 1).
Discussion
It is common-ly accepted that an abnormality in lipid metabolism is intimately associated with the pathogenesis of atherosclerosis. '19 20 Knowledge of the particular lipids involved or of a precise mechanism is still lackinog. In fact, it would appear that this and even the entire subject of atherogenesis and the signifieance of various proposed laboratory diag- atheroselerotic status of the individual. These findings are in agreement with those of Wagner and Poinidexter26 as well as Sperry,35 who stated, ''unless the total cholesterol content of serum of a patient is extremiiely low or high, we can not be certain that the amount found is abnormal for that person. " Therefore, a manifest weakness of this determination is revealed by the fact that an overwhelminig majority of a random population may be expected to fall withini the nonsignificant range.
Although phospholipids may play an important role in the solubility of cholesterol and other lipids, from our data at least, their serum concentration per se has no significance in revealing the atherosclerotic status of either the individual or groups. Contrariwise, it may be concluded that the extremely low Fisher t value which we have observed tends to establish an identity betweeni normal and atherosclerotic subjects with respect to this lipid component. In a sense this is not surprising, since the concentration of phospholipids roughly parallels that of total lipids in the blood, an observation supported by a high coefficient of correlation (r = 0.91).
The cholesterol/phospholipid ratio appears to be a function of the change in the serum cholesterol level,20 which is demonstrated by the similarity in the continuous curves showni It will be noted that total lipid measurenmients provide a poor index for establishing differences both between normal and atherosclerotic groups and with respeet to identifying individuals, since this variable shows zero reliablity at every level of concentration. This presumably is related closely to the dietary habits of the individual.
Lipoprotein analyses by paper electrophoresis have yielded considerable variation in results reported by different laboratories. 9' 18, 31 This variation is confirmed by our myocardial infarets, show scatter diagrams in whieh the degree of overlap between these 2 groups reveals that it is impossible to distiiiguish more than a very small fraetion of the population on an individual basis.
In order to compare Gofmani's atherogenic index with ours we have replotted Gofmani's data22 concerned with Sf 12-20 lipoproteins ( fig. 13 ). Remarkably similar trends are note(d between Gofman's index and our beta/alpha ratios ( fig. 11 ) but more detailed anialysis is not possible without the original data.
Unquestionably an area of overlapping values exists in all such determinations. This can be accounted for by our inability to separate adequately the symptomless atherosclerotic individual from the true normal. In addition, this area of doubt is also contributed to by a considerable number of individuals who, having displayed evidence of coronary artery disease, spontaneously or through medical management, may have adjusted their lipid metabolism so as to interrupt the phenomenon of atherogenesis. This type of course would suggest, therefore, that the pathogenesis of the disease may not be a continuous but rather an intermittent process, and in a sense holds promise for its eventual management. The myocardial infaretion, the coronary insufficiency, and the thrombosis are the result of the coronary atherosclerosis, which itself is a secondary manifestation of an underlying metabolic disease. An abnormal atherogenic index in terms of lipoproteins, therefore, must be construed to imply the developing phase of the disease of the arterial wall per se, and not necessarily the extent to which it exists at the time of sampling.
The data thus far discussed appear to warrant further investigation to include a larger population, which is currently in process. 
